InvestorsHub Logo
Followers 199
Posts 25122
Boards Moderated 0
Alias Born 04/03/2010

Re: iclight post# 590936

Thursday, 05/04/2023 11:33:28 PM

Thursday, May 04, 2023 11:33:28 PM

Post# of 730467
So. NWBO looks like it has a successful trial that suggests they also have a tumor agnostic immunotherapy that is easy to accept, has virtually no side-effects and could have a very high survival and possibly “cure” rate when used in combination with or with adjuvants.

NVCR has a treatment that the UK and some US states find reason to doubt is even worth providing.

I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News